MIR8065

Across TCGA pan-cancer cohorts, MIR8065 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR8065 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR8065 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR8065 expression acts as an unfavorable survival marker.

HNSC, UVM, and OV are the cancer types where MIR8065 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	II,III,IV	0.100	0.695	<.001	90	view →
UVM	DFS	Tertile	All	0.141	0.745	.011	36	view →
OV	OS	Tertile	All	0.360	0.691	.004	36	view →
KIRC	DFS	Tertile	All	0.675	0.868	.011	24	view →
LAML	DFS	Tertile	All	0.028	0.583	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR8065–HNSC (DFS)

Open the HNSC breakdown →